The OHF Corporate Alliance is a coalition of Hyperoxaluria stakeholders that are committed to collaboration between industry and the OHF community to improve and expedite access to effective therapies for all patients.
Membership is open to pharmaceutical and biotech companies, industry, service firms and academia that want to support patient education, community building and improved access to approved treatments. Contact us at info@ohf.org to learn more about becoming a Corporate Alliance member.
The members that OHF partners with have a patient focus, community-centered approach and like-minded vision for the future.
Corporate Alliance Members
